Pricing people out of using Mounjaro would be bad news for the NHS - COMMENT: The astronomical rise in weight-loss drug prices caused by Trump’s tariffs could have a significant – and dangerous – ...

The programme includes a nationwide competition for NHS organisations to submit innovative new models of obesity care.